These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10650577)

  • 1. [Reversibility of severe hyperlipemia secondary to indinavir with micronized phenofibrate].
    de Luis DA; Aller R; Rachiller P; Ignacio Tortosa J
    Med Clin (Barc); 1999 Nov; 113(18):716-7. PubMed ID: 10650577
    [No Abstract]   [Full Text] [Related]  

  • 2. Fenofibrate in hyperlipidaemia secondary to HIV protease inhibitors. Fenofibrate and HIV protease inhibitor.
    de Luis DA; Bachiller P; Aller R
    Nutrition; 2001 May; 17(5):414-5. PubMed ID: 11377136
    [No Abstract]   [Full Text] [Related]  

  • 3. Pravastatin in hyperlipidemia secondary to HIV protease inhibitors without response to fenofibrate: a brief preliminary report.
    de Luis DA; Bachiller P; Aller R; Eiros Bouza J; Izaola O
    Nutrition; 2003 Oct; 19(10):903-4. PubMed ID: 14559329
    [No Abstract]   [Full Text] [Related]  

  • 4. Micronized fenofibrate in the management of dyslipidemia.
    Steiner G
    Diabetes Care; 1998 Nov; 21(11):2039-40. PubMed ID: 9802773
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperlipidemia related to the use of HIV-protease inhibitors: natural history and results of treatment with fenofibrate.
    Caramelli B; de Bernoche CY; Sartori AM; Sposito AC; Santos RD; Monachini MC; Strabelli T; Uip D
    Braz J Infect Dis; 2001 Dec; 5(6):332-8. PubMed ID: 11980596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperlipidemia in patients with HIV infection treated with protease inhibitors].
    López García F; Mora Rufete A; Escolano Hortelano CM; Gutiérrez Rodero F
    Rev Clin Esp; 1999 Nov; 199(11):780-1. PubMed ID: 10638253
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperlipidemia associated with the use of protease inhibitors.
    Smith JH; Martin GJ; Decker CF
    Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432
    [No Abstract]   [Full Text] [Related]  

  • 8. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
    Manfredi R; Chiodo F
    J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal atrophy associated with long-term treatment with indinavir.
    Hanabusa H; Tagami H; Hataya H
    N Engl J Med; 1999 Feb; 340(5):392-3. PubMed ID: 9988612
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients.
    Chang ES; Tetreault DD; Liu YT; Beall GN
    J Am Diet Assoc; 2001 Jun; 101(6):687-9. PubMed ID: 11424549
    [No Abstract]   [Full Text] [Related]  

  • 11. Apolipoprotein A-V genetic variation and plasma lipoprotein response to fibrates.
    Hegele RA; Pollex RL
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1224-7. PubMed ID: 17522394
    [No Abstract]   [Full Text] [Related]  

  • 12. Indinavir sulfate renal toxicity in a pediatric hemophiliac with HIV infection.
    Ascher DP; Lucy MD
    Ann Pharmacother; 1997 Oct; 31(10):1146-9. PubMed ID: 9337438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute thrombocytopenia secondary to the administration of the peptidomimetic HIV protease inhibitor MK-639(L735524).
    Stein DS; Dunn H; Drusano GL
    AIDS; 1996 Jun; 10(6):678-80. PubMed ID: 8780825
    [No Abstract]   [Full Text] [Related]  

  • 14. Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia.
    Mastroianni CM; d'Ettorre G; Forcina G; Lichtner M; Corpolongo A; Coletta S; Vullo V
    AIDS; 2001 Apr; 15(6):820-1. PubMed ID: 11371708
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of fibrates in the management of hyperlipidemia in HIV-infected patients receiving HAART.
    Calza L; Manfredi R; Chiodo F
    Infection; 2002 Jan; 30(1):26-31. PubMed ID: 11876511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A side effect of protease inhibitors.
    Teitel J
    CMAJ; 1998 May; 158(9):1129-30. PubMed ID: 9597957
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet dysfunction as the cause of spontaneous bleeding in two haemophilic patients taking HIV protease inhibitors.
    Pollmann H; Richter H; Jürgens H
    Thromb Haemost; 1998 Jun; 79(6):1213-4. PubMed ID: 9657450
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe coronary artery disease in a young HIV-infected man with no cardiovascular risk factor who was treated with indinavir.
    Karmochkine M; Raguin G
    AIDS; 1998 Dec; 12(18):2499. PubMed ID: 9875590
    [No Abstract]   [Full Text] [Related]  

  • 19. Indinavir and thrombocytopenia.
    Durand JM
    AIDS; 1999 Jan; 13(1):148-9. PubMed ID: 10207566
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe hypertension and renal atrophy associated with indinavir.
    Cattelan AM; Trevenzoli M; Naso A; Meneghetti F; Cadrobbi P
    Clin Infect Dis; 2000 Mar; 30(3):619-21. PubMed ID: 10722466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.